In Drug Discovery the first pharmacokinetic in vivo study of new compounds is of great importance to provide an initial assessment of the drug pharmacokinetik (PK) parameters. Data from these studies is used to optimize the PK properties of the chemical series and to calculate the initial doses in further in vivo studies. Because of the everexisting demand to increase throughput in Drug Discovery, ...